Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial | PLOS ONE
The Pulmonary Vasculitides - ppt video online download
![PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/51ebf4558271a5eedd8568631edf87751abe1e87/8-Table5-1.png "PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar")
PDF] Clinical features and prognostic factors of Churg-Strauss syndrome | Semantic Scholar
PDF) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Evolutions in classification, etiopathogenesis, assessment and management | Ulrich Specks - Academia.edu
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
Christian Pagnoux, MD MSc MPH 19 November 2015
Frontiers | Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis
PDF) Update on eosinophilic granulomatosis with polyangiitis
Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial | PLOS ONE
Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study | Arthritis Research & Therapy | Full Text
PDF) Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience
PDF) Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: A retrospective study
PDF) Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis
Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials - ScienceDirect
The Korean Journal of Internal Medicine
MAINtenance of remission with RITuximab versus azathioprine for patients with newly-diagnosed or relapsing Eosinophilic Granulom
The Korean Journal of Internal Medicine
2 Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndro
Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Metaâ•'Analysis of Test Accuracy and Benefits and Ha
Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review
Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss; EGPA): to use or not to use? | Annals of the Rheumatic Diseases
PDF) Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis
